Navigation Links
Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in,Lamellar Ichthyosis

rmal proliferation and differentiation of skin cells.

Liarozole was placed on clinical hold by the FDA in 2006 and no clinical studies in humans may be initiated in the U.S. until the FDA's concerns are addressed. Based on feedback from EMEA we believe it is highly likely that a long term safety study and an efficacy comparator trial against the current standard of care would be required in order to make a submission for regulatory approval in Europe. The Company does not plan to do any additional development work in either the U.S. or the EU.

Liarozole has received orphan drug designation from both the U.S. Food and Drug Administration (FDA) and the European Commission for the treatment of congenital ichthyosis.

About Congenital Ichthyosis and Lamellar Ichthyosis

Congenital ichthyosis represents a family of rare, debilitating skin disorders characterized by drying and scaling of the skin and affects approximately 40,000 people in the United States. These disorders may result in excessive fluid loss, increased risk of infection and chronic lesions that can be painful and disfiguring, which in turn have significant social and psychological impact. In infants, certain types of congenital ichthyosis can be life-threatening. No prescription drugs are currently approved to treat these conditions in the United States. Lamellar ichthyosis is specific sub-type of congenital ichthyosis. Congenital ichthyosis is distinct from ichthyosis vulgaris, a more common, less severe and easier to manage form of ichthyosis.

About Barrier Therapeutics

Barrier Therapeutics, Inc. is a pharmaceutical company focused on the development and commercialization of products in the field of dermatology. Barrier Therapeutics currently markets three pharmaceutical products in the United States: Xolegel(TM) (ketoconazole, USP) Gel, 2%, for seborrheic dermatitis; Vusion(R) (0.25% miconazole nitrate, 15% zinc oxide, 81.35% white petrolatum) Ointment, for diaper
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:3/30/2015)... WILMINGTON, Del. , March 30, 2015  Rigrodsky & ... Auspex Pharmaceuticals, Inc. (NASDAQ GM: ASPX )? , ... 30, 2015? , Do you think the proposed buyout ... discuss your rights? Rigrodsky & Long, ... against the board of directors of Auspex Pharmaceuticals, Inc. ("Auspex" ...
(Date:3/30/2015)... DIEGO , March 30, 2015  Orexigen ... that Tom Cannell has joined as ... global commercialization of Contrave® /Mysimba™ (naltrexone HCl / ... aspects of Orexigen,s global commercial strategy, assuming responsibilities ... successfully leading Orexigen,s commercial effort through the U.S. ...
(Date:3/30/2015)... 30, 2015  New York College of Health Professions ... Properties portfolio with U.S. Patent #8,996,098 donated by its ... represents a surgical instrument that allows surgeons to view ... were in the traditional format of a slide that ... databases during surgery, thus providing the surgeon real time ...
Breaking Medicine Technology:AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3
... (Nasdaq: YDNT ) today announced that it will ... on-demand web cast conference call on Thursday, October 21, 2010 ... the call will be available through InterCall at http://tinyurl.com/Quarter32010 ... available through the Company,s website, www.ydnt.com . ...
... one of the world,s largest and most sophisticated pharmacies ... (D-Nev.), today said innovative companies such as Medco Health ... bright future for a sustainable healthcare system for America ... Nevada by providing employment opportunities for skilled healthcare professionals. ...
Cached Medicine Technology:Young Innovations, Inc. Provides 3rd Quarter Conference Call Details 2Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevada's Future 2Sen. Harry Reid to Medco Employees: Technology and Innovation Integral to Sustainable Healthcare Reform and Nevada's Future 3
(Date:3/30/2015)... Georgia (PRWEB) March 30, 2015 Innovaacom, ... healthcare professionals worldwide, today announced it is expanding its ... solutions for this area of the world comes at ... rallying around consumer demand for better healthcare. A rapidly ... healthcare system improvements and advances in medicine in Asia. ...
(Date:3/30/2015)... 2015 A key protein previously implicated ... an important role in the response to viral infection, ... Icahn School of Medicine at Mount Sinai published today ... been associated with inflammation, part of the body’s response ... home in to attack invaders like bacteria and viruses, ...
(Date:3/30/2015)... According to a recently published report ... market will continue to dominate the European soft tissue ... to increasing numbers of ventral hernias, and the adoption ... significantly large market share represented by ventral hernia repair ... seeing a growing use of expensive biologics,” explains Dr. ...
(Date:3/30/2015)... In a recent report published by ... is championing effective drug and alcohol treatment for victims ... recover funds to stabilize the addiction treatment programs, and ... drug and alcohol addiction. Harbor Village Detox is extending ... use disorders in New Jersey, in hopes to help ...
(Date:3/30/2015)... March 30, 2015 Vancouver personal injury ... the majority of cases taken up by the firm ... that the lawyers help protect the interests of their ... court process. The announcement comes across as an achievement ... is to provide convenience to their client, without compromising ...
Breaking Medicine News(10 mins):Health News:Innovaacom Expands Services and Medical Education Programs into Asia 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 2Health News:Mount Sinai Scientists Establish Link Between Neurodegenerative Disease and the Body’s Response to Viral Infection 3Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 2Health News:High Prices for Advanced Biologic Hernia Repair Technology Driving European Soft Tissue Reinforcement and Regeneration Market Growth 3Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2
... beware. You may be more prone to an alcohol-induced ... from the Jefferson Headache Center. The research will be ... Society for Neuroscience, in Chicago. Until now, studying ... headaches has not been possible in an animal model, ...
... like norepinephrine, serotonin, and dopamine, are regulated a ... Current drugs for depression target the regulatory process for ... appear to work in other cases. Recent ... in the brain, are key players in the management ...
... the pain, experts say , SUNDAY, Oct. 18 (HealthDay News) -- ... it,s no surprise that children will try to flee, scream, cry ... year. , "The good news is that there are several ... when getting a needlestick -- whether it,s a flu shot, a ...
... CHICAGO Epileptic seizures are the most dramatic and ... when a person abruptly stops a long-term or chronic ... calcium ions into brain cells via voltage-gated calcium channels ... withdrawal seizures, because blocking this flow suppresses these seizures. ...
... disorder more likely to die within a year of ... News) -- Veterans with post-traumatic stress disorder face an ... surgery is performed years after they have completed their ... data on 1,792 male veterans who had major non-cardiac, ...
... BOCA RATON, Fla., Oct. 16 Certain cookie diets recently ... nutrition and having no apparent health benefits. Smart for Life ... it is a healthy lifestyle featuring products that are all-natural, ... Smart for Life is a healthy lifestyle that has become ...
Cached Medicine News:Health News:Migraine sufferers more prone to hangover headache 2Health News:Post-Traumatic Stress May Raise Death Risks 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 3
... 2201 is ideal for applications such ... of heat. , ,The autoclavable handpiece ... of reusable thermal cautery electrodes, allowing ... to perform a wide variety of ...
Non-Cantilevered, "Teardrop" Ringed Forceps. ("fixation clamp") For vasectomy and other procedures. Ring ovoid approximately 6.0 mm in diameter....
... Stethoscope Module is an inconspicuous, lightweight, battery-operated instrument ... hear body functions amplified., ,The module controls ... switch, a tone switch, a stethoscope hearing aid ... switch will allow the user to select between ...
... ring receiver type earmold for ... of your ears are required. ... for the ear are distributed ... hearing healthcare providers. These providers ...
Medicine Products: